SINOVAC BIOTECH LTD
corporate_fare Company Profile
SINOVAC BIOTECH LTD (NASDAQ:SVA) is a publicly traded company in the Life Sciences sector. Wiseek monitors SVA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Sinovac Biotech Reports $59.7M Net Loss for 2025, $202.8M Impairments, and $3.3B Special Dividend
- Sinovac Biotech Files 20-F with Adverse Auditor Opinion on Internal Controls, Faces Nasdaq Delisting
- Sinovac Biotech Faces Nasdaq Delisting Threat for Late 2025 Annual Report, Requests Hearing
- Nasdaq Warns Sinovac Over Late 2025 Annual Report Filing Amid Prior Financial Issues
- Sinovac Reports $4.0 Billion Special Dividend and Swings to Net Loss Amidst H1 2025 Operational Challenges
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$386.01M
Net Income
-$198.84M
Diluted EPS
-$0.83
Op. Cash Flow
-$512.18M
Free Cash Flow
-$561.1M
Gross Profit
$261.98M
Operating Income
-$490.13M
Cash & Equivalents
$488.25M
Total Debt
$265.48M
Debt / Equity
0.06×
Net Margin
-51.5%
Shares Outstanding
71.86M sh
Source: 20-F · filed 2026-06-05 · accession 0001193125-26-258534
Insider Transactions
SVA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed SVA - Latest Insights
SVA
Jun 05, 2026, 4:30 PM EDT
SVA
Jun 05, 2026, 9:27 AM EDT
SVA
May 29, 2026, 5:00 PM EDT
SVA
May 29, 2026, 4:02 PM EDT
SVA
May 08, 2026, 5:21 PM EDT
SVA
Apr 30, 2026, 9:17 AM EDT
SVA
Jan 30, 2026, 3:24 PM EST
SVA
Jan 30, 2026, 3:24 PM EST
SVA
Jan 30, 2026, 3:24 PM EST
SVA
Jan 30, 2026, 3:23 PM EST
SVA
Jan 30, 2026, 3:23 PM EST
SVA
Jan 30, 2026, 3:23 PM EST